JP Morgan Knock-Out RWE/ DE000JQ5Z8Z7 /
| 2024-07-25 5:52:10 PM | Chg.+0.01 | Bid7:51:12 PM | Ask7:51:12 PM | Underlying | Strike price | Expiration date | Option type |
|---|---|---|---|---|---|---|---|
| 1.76EUR | +0.57% | 1.76 Bid Size: 20,000 |
1.79 Ask Size: 20,000 |
RWE AG INH O.N. | 50.7856 - | 2078-12-31 | Put |
GlobeNewswire
06-25
Annexon Presented Additional Positive Phase 3 Results for ANX005 C1q-Targeted Immunotherapy in Guill...
GlobeNewswire
06-18
Truveta announces support for regulatory submissions to the FDA and global regulatory authorities
GlobeNewswire
06-12
RWE Announces Start of Site Investigation Campaign for its Canopy Offshore Wind Project off the Coas...
GlobeNewswire
06-11
RWE begins onsite construction on its first utility-scale solar project in Illinois to support rapid...
GlobeNewswire
06-05
Intuitive Announces FDA Clearance of Revised da Vinci Xi and X Labeling on Radical Prostatectomy
GlobeNewswire
06-04
Annexon Announces Positive Topline Results from Pivotal Phase 3 Trial for First-in-Class C1q Blockin...
GlobeNewswire
05-23
RWE signs two 15-year Power Purchase Agreements with Microsoft to supply clean energy from two onsho...
GlobeNewswire
05-20
RWE expands U.S. development portfolio with new project acquisitions across three states
GlobeNewswire
05-13
Annexon Reports First Quarter 2024 Financial Results and Key Anticipated Milestones
GlobeNewswire
05-02
Using clinical-led AI, Truveta expands clinical notes and medical images available to advance resear...
GlobeNewswire
04-25
Truveta delivers largest and most complete mother and child EHR dataset to advance healthcare
